Chief Financial Officer
Bob McMullan is an accomplished senior financial executive and board member with significant experience in leading growth in various industries.
Prior to joining Pharmscript, Bob was a Senior Vice President and Chief Financial Officer of MACOM Technology Solutions, Inc. (NASDAQ:MTSI) where he contributed to their doubling of revenues and earnings over a four year period and completed numerous portfolio acquisitions and divestitures and multiple public financings to support its growth. Prior to MACOM, Bob has held Chief Financial Officer roles and executive leadership positions with numerous private and public companies including, Conexant Systems, Inc. (NASDAQ:CNXT), Globespan Virata, Inc. (NASDAQ:GSPN) and The BISYS Group, Inc. (NASDAQ:BSYS), among others.
As a senior financial executive, Bob has secured billions in various forms of debt and equity financings. Bob has completed over 60 acquisitions including the integration of the acquisitions and executed 12 business divestitures. Operationally, Bob has a proven history of unbiased discipline in evaluating strengths and weaknesses of an organization and implementing change, with a laser focus on maximizing profitability and enhancing shareholder value.
Bob holds a Bachelor of Arts in Business Administration from St. Michael’s College. He has served on the Board of The Peck School, as Trustee & Treasurer; Control Point Solutions as Director and Acting Chairman; Bancroft Convertible Fund, Inc., Ellsworth Growth & Income Fund, and AmSouth Funds as an independent Trustee and member of the Audit Committees. Bob chaired the audit committees of Bancroft and Ellsworth funds.